Immune to Cancer: The CRI Blog
-
Childhood Cancer Awareness Month: 2021 Immunotherapy Research Updates
This September for Childhood Cancer Awareness Month, we look at new research, new treatments, and how we…
-
Childhood Cancer Awareness Month: 2020 Immunotherapy Research Updates
This September for Childhood Cancer Awareness Month, we look at how we’re working toward a future immune…
-
Childhood Cancer Awareness Month: 2019 Immunotherapy Research Update
For Childhood Cancer Awareness Month, we round up the latest news and research from the people changing…
-
How Immunotherapy is Impacting Pediatric Cancer
We spoke with Susanne Baumeister, MD, about the current treatment landscape in childhood cancer, including immunotherapy and…
-
FDA Approves First-In-Class CAR T Cell Immunotherapy for Leukemia
Children and young adults with relapsed/refractory acute lymphoblastic leukemia (ALL) can now receive the CD19-targeting CAR T…
-
Pembrolizumab Approved for Children and Adults with Hard-to-Treat Hodgkin Lymphoma
Pembrolizumab is second anti-PD-1 drug approved for adults with cHL, first for any childhood cancer